Although further studies are needed to determine the clinical relevance of the AAV1–Rheb(S16H) transduction approach for neurodegenerative diseases, this approach may be a useful strategy for protecting hippocampal neurons in the lesioned brain, and its effects may be beneficial for patients with neurodegenerative diseases such as AD. The gene discussed is RHEB; the disease is neurodegenerative disease.